Dr Byrd discusses optimizing Ibrutinib & Idela... - CLL Support
Dr Byrd discusses optimizing Ibrutinib & Idelalisib.
You need to be a member of this community to see this post.
Read more about...
5 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Dr Sharman's thoughts on the race for FDA Approval for Obinituzumab, Ibrutinib and Idelalisib
to-stop-phase-3-study-116-of-idelalisib-in-chronic-lymphocytic-leukemia-early-because-of-positive-ri
Dr. Mato on what really happens when we must stop our ibrutinib or idelalisib
http://cllsociety.org/2016/05/ash-2015-happens-cll-patient-stop-ibrutinib-idelalisib ]
I also wrote...
Dr. Byrd on COVID-19
Dr. John Byrd is not only a valued member of our medical advisory board and a world leader in CLL...
Possible side effects from Ibrutinib & Idelalisib
As Ibrutinib and Idelalisib become more widely used among non CLL Specialists I have some concerns...
Your opportunity to support affordable access to Ibrutinib and Idelalisib for Aussies - Submissions close next Wed 7th October
will consider listing Idelalisib and Ibrutinib for CLL patients.
Idelalisib is on the...
Idelalisib Trial frozen!
Pneumonia from Idelalisib 
